Chronic traumatic encephalopathy should be recognized as a distinct cause of dementia, study finds

The largest study of its kind from the Boston University CTE Center reveals that chronic traumatic encephalopathy (CTE) ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Spectrum News NY1

Gunman who blamed NFL for hiding brain injury dangers had CTE, medical examiner confirms

The former high school football player who killed four people inside a Manhattan office tower that houses the headquarters of the NFL, and who blamed the league for hiding the dangers of brain ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...